These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3026132)

  • 1. Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies.
    Kumanishi T; Washiyama K; Saito T; Nishiyama A; Abe S; Tanaka T
    Acta Neuropathol; 1986; 71(3-4):190-6. PubMed ID: 3026132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical analysis of T cells in primary B cell malignant lymphoma of the brain.
    Nishiyama A; Saito T; Abe S; Kumanishi T
    Acta Neuropathol; 1989; 79(1):27-9. PubMed ID: 2589022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ immunologic characterization of follicular lymphomas.
    Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F
    Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study on "neoplastic angioendotheliosis": demonstration of B lymphocyte markers in the neoplastic cells.
    Abe S; Shimbo Y; Saito T; Kohno M; Nishiyama A; Kumanishi T
    Acta Neuropathol; 1988; 75(3):313-6. PubMed ID: 3258083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.
    Pallesen G; Beverley PC; Lane EB; Madsen M; Mason DY; Stein H
    J Clin Pathol; 1984 Aug; 37(8):911-8. PubMed ID: 6381546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
    Norton AJ; Isaacson PG
    Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of large-cell lymphomas using monoclonal and heterologous antibodies.
    van der Valk P; van den Besselaar-Dingjan G; Daha MR; Meijer CJ
    J Clin Pathol; 1983 Jan; 36(1):44-50. PubMed ID: 6337190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus.
    Chang KL; Flaris N; Hickey WF; Johnson RM; Meyer JS; Weiss LM
    Mod Pathol; 1993 Jul; 6(4):427-32. PubMed ID: 8415586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of cell surface antigens on tissue sections of lymphomas.
    Hoffmann-Fezer G; Thierfelder S; Pielsticker K; Rodt H
    Leuk Res; 1979; 3(5):297-304. PubMed ID: 392200
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of lymphoid subpopulations in normal and malignant tissues by immunofluorescence techniques.
    Janossy G; Thomas JA; Pizzolo G
    J Cancer Res Clin Oncol; 1981; 101(1):1-11. PubMed ID: 6456270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
    Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
    Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.